Date published: 2026-4-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Brilliant Blue G (CAS 6104-58-1)

5.0(1)
Write a reviewAsk a question

See product citations (11)

Alternate Names:
Coomassie Brilliant Blue G (CBBG)
Application:
Brilliant Blue G is a commonly used analytical biochemistry dye and P2X7 antagonist
CAS Number:
6104-58-1
Molecular Weight:
854.02
Molecular Formula:
C47H48N3O7S2•Na
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Brilliant Blue G (CBBG) is a member of the Coomassie dye family and is commonly used in analytical biochemistry to stain proteins in SDS-PAGE and BN-PAGE. CBBG is a useful component in the Bradford Method, a dye-binding protein assay employed to determine protein concentration in a given solution. CBBG can exist in three forms: a cation (red form with maximum absorbance at 470 nm), a neutral form (green with maximum at 650 nm), and an anionic form (blue with maximum at 595 nm). The anionic form initiates a stable complex with basic amino acid residues, mainly arginine and aromatic amino acids. Although the anionic form exists in negligible concentrations at the assay reaction mixture's pH, the protein-binding shifts the equilibrium toward its formation. Recent research reveals CBBG as a P2X7 (P2X purinoceptor 7: P2RX7) antagonist and suggests that it exhibits neuroprotective properties in rat spinal cord cells.


Brilliant Blue G (CAS 6104-58-1) References

  1. Evaluation of Coomassie blue staining of the acrosome of equine and canine spermatozoa.  |  Brum, AM., et al. 2006. Am J Vet Res. 67: 358-62. PMID: 16454645
  2. A modified Coomassie Brilliant Blue staining method at nanogram sensitivity compatible with proteomic analysis.  |  Wang, X., et al. 2007. Biotechnol Lett. 29: 1599-603. PMID: 17563857
  3. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form.  |  Schägger, H. and von Jagow, G. 1991. Anal Biochem. 199: 223-31. PMID: 1812789
  4. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury.  |  Peng, W., et al. 2009. Proc Natl Acad Sci U S A. 106: 12489-93. PMID: 19666625
  5. Development and validation of an improved Bradford method for determination of insulin from chitosan nanoparticulate systems.  |  Su, ZQ., et al. 2010. Pharm Biol. 48: 966-73. PMID: 20731546
  6. Efficacy of inverted inner limiting membrane flap technique for macular holes of ≤400 μm: A systematic review and meta-analysis.  |  Lee, SM., et al. 2024. PLoS One. 19: e0302481. PMID: 38683767
  7. Moderate physical exercise and ATP modulate the P2X7 receptor and improve cisplatin-induced gastric emptying delay in rats.  |  Gomes, YA., et al. 2024. Braz J Med Biol Res. 57: e13234. PMID: 38716980
  8. Prediction of long-term visual outcome of idiopathic full-thickness macular hole surgery using optical coherence tomography parameters that estimate potential preoperative photoreceptor damage.  |  Bajdik, B., et al. 2024. Graefes Arch Clin Exp Ophthalmol.. PMID: 38717606
  9. Effect of vanadate on protein determination by the coomassie brilliant blue microassay procedure.  |  Matejovicova, M., et al. 1997. Anal Biochem. 245: 252-4. PMID: 9056222
  10. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.  |  Bradford, MM. 1976. Anal Biochem. 72: 248-54. PMID: 942051

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Brilliant Blue G, 5 g

sc-203733
5 g
$39.00

Brilliant Blue G, 25 g

sc-203733A
25 g
$99.00